Cyclacel Pharmaceuticals, Inc. (BGMS)
NASDAQ
Cyclacel Pharmaceuticals, Inc. Total Liabilities 2024–2025
Cyclacel Pharmaceuticals, Inc. annual total liabilities history from 2024 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Cyclacel Pharmaceuticals, Inc. total liabilities as of December 31, 2025: 1.3M, a 78.57% decrease year-over-year.
- Cyclacel Pharmaceuticals, Inc. total liabilities for 2025 were 1.3M, a 78.57% decrease from 2024.
- Cyclacel Pharmaceuticals, Inc. total liabilities for 2024 were 6.3M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Cyclacel Pharmaceuticals, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $1 |
| 2024 | $6 |
Cyclacel Pharmaceuticals, Inc. Total Liabilities — FAQ
Cyclacel Pharmaceuticals, Inc. (BGMS) total liabilities over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BGMS's total liabilities history?
The chart and table above show Cyclacel Pharmaceuticals, Inc.'s total liabilities by year and by quarter, including the growth rate.